1. Home
  2. NKLR vs EBS Comparison

NKLR vs EBS Comparison

Compare NKLR & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NKLR

Terra Innovatum Global N.V. Ordinary shares

HOLD

Current Price

$5.93

Market Cap

500.6M

Sector

Industrials

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$5.97

Market Cap

413.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NKLR
EBS
Founded
2018
1998
Country
Italy
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
500.6M
413.3M
IPO Year
2025
2006

Fundamental Metrics

Financial Performance
Metric
NKLR
EBS
Price
$5.93
$5.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$15.00
$12.00
AVG Volume (30 Days)
408.9K
1.4M
Earning Date
04-01-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
N/A
Revenue
N/A
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.73
$4.36
52 Week High
$12.43
$14.06

Technical Indicators

Market Signals
Indicator
NKLR
EBS
Relative Strength Index (RSI) 54.89 51.75
Support Level $4.01 $4.36
Resistance Level $6.47 $8.59
Average True Range (ATR) 0.38 0.28
MACD -0.03 0.22
Stochastic Oscillator 46.07 98.78

Price Performance

Historical Comparison
NKLR
EBS

About NKLR Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor SOLO. SOLO is compact yet extremely powerful with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: